PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 14, 2026Open Forum Infectious Diseases0 citationsOpen Access

P-1460. Ion Channels as Targets of an Anti-Tick Vaccine

View Full Paper
JMJacob F. MyersMSMatthias Schnell

Key Points

  • This research aims to explore the role of antibodies against ion channels in controlling tick populations.
  • Designed a peptide-based vaccine targeting GluCl,
  • Vaccinated mice to induce antibody responses,
  • Analyzed tick mortality after exposure to vaccinated mouse blood.
  • Conducted Fisher’s Exact Test for statistical significance of results.
  • Tick mortality rates were observed at 84.8% for positive control,
  • 90.6% for GluCl vaccinated mice, and 31.3% for negative control,
  • Strong significance was found between GluCl and negative control (p<0.0001),
  • GluCl vs. positive control was non-significant (p=0.70).

Abstract

Abstract Background Background- Ticks vector numerous diseases and are a growing public health concern as the incidence of tick vectored disease continues to increase. Tick vectored disease is heterogenous, limiting the impact of disease specific approaches and making the control of ticks themselves an attractive solution. Traditional chemical approaches to vector control are facing increasing challenges. When ticks ingest host blood, they also ingest antibodies, and if these antibodies bind to and disrupt these ion channels then vaccination could turn animals into walking reservoirs of a biologic acaricide as part of a One Health approach to preventing human disease. Methods Methods- We aim to design a vaccine that induces immunity that kills ticks when they feed on a vaccinated host. We’ve identified the Glutamate Gated Chloride Channel (GluCl), the target of Ivermectin, as an ideal vaccine target. Previous studies showed that antibodies against GluCl could inhibit the GluCl and kill mosquitos when ingested with a bloodmeal. However, GluCl antibodies were limited by needing to “leak” out of the gut to reach their targets. Ticks are an ideal system to study GluCl vaccination because tick guts are orders of magnitude “leakier” to antibodies than mosquitos and ticks imbibe more blood. Results Results- We designed and characterized a peptide-based vaccine against GluCl. We vaccinated mice with this candidate vaccine and recorded strong antibody reactions against GluCl. We microinjected ticks with 1) Ivermectin as a positive control or purified polyclonal IgG in PBS from 2) mice given a negative control vaccination, or 3) mice vaccinated with GluCl peptides. Tick mortality was 1) 84.8% 2) 31.3%, and 3) 90.6%, respectively. Fisher’s Exact test analysis of GluCl vs Negative Control yields a strongly significant effect (p= 0.0001) while GluCl vs. Positive Control is non-significant (p=0.70). Conclusion Conclusions- We have successfully shown that antibodies against an ion channel like the GluCl can exert a toxic effect in ticks. Future work will seek to explore the impact of these antibodies following natural feeding on a vaccinated animal and the potential of these approaches to interrupt cycles of disease transmission. Disclosures All Authors: No reported disclosures

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Myers et al. (2026) studied this question.

synapsesocial.com/papers/6966f30613bf7a6f02c00936https://doi.org/10.1093/ofid/ofaf695.1646
Ask AI
Helpful
Bookmark
Share
View Full Paper